Back to results
US 2007/0190049 A1Published application
Use of A33 antigens and JAM-IT
OwnerAvi Ashkenazi, Sherman Fong +6inventors
InventorsAvi Ashkenazi, Sherman Fong, Audrey Goddard, Austin Gurney, Mary Napier, Daniel Tumas, Menno Lookeren, William Wood
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions and methods of treating and diagnosing disorders characterized the by the presence of antigens associated with inflammatory diseases and/or cancer.
Claims4
A polypeptide comprising amino acids 21 to 180 of SEQ ID NO:
- 34.
An immunoadhesin comprising amino acids 21 to 180 of SEQ ID NO:
- 34, fused to an immunoglobulin constant region sequence.
Dependencies are inferred from the claim text.